Wallace Weitz's RGEN Position Overview
Wallace Weitz (via Weitz Investment Management, Inc.) currently holds 25,500 shares of Repligen Corporation (RGEN) worth $3 M, representing 0.21% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Wallace Weitz has initiated a new position in RGEN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Wallace Weitz's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Wallace Weitz
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +25,500 | New Buy | 25,500 | $117.82 |
Wallace Weitz's Repligen Corporation Investment FAQs
Wallace Weitz first purchased Repligen Corporation (RGEN) in Q1 2026, acquiring 25,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Wallace Weitz has held Repligen Corporation (RGEN) for 1 quarters since Q1 2026.
Wallace Weitz's largest addition to Repligen Corporation (RGEN) was in Q1 2026, adding 25,500 shares worth $3 M.
According to the latest 13F filing for Q1 2026, Wallace Weitz's firm, Weitz Investment Management, Inc., owns 25,500 shares of Repligen Corporation (RGEN), valued at approximately $3 M.
As of the Q1 2026 filing, Repligen Corporation (RGEN) represents approximately 0.21% of Wallace Weitz's publicly disclosed stock portfolio, making it one of their key holdings.
Wallace Weitz's peak holding in Repligen Corporation (RGEN) was 25,500 shares, as reported at the end of Q1 2026.